Savings totaled $293 billion in 2018.
Abbreviated New Drug Applications, state laws, and more.
Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
Biosimilars may need more time to devleop in the market.
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
New changes are making it more difficult for generics and biosimilars to compete on formularies.
First generic specialty injections approved for Novadoz Pharmaceuticals.
Update: now available from three manufacturers.
Xellia Pharmaceuticals will manufacture essential antibiotics for Civica Rx.
Suit filed in Connecticut alleges companies conspired to inflate prices on more than 100 generic drugs.